The expression of Bmal1 is decreased in human pancreatic ductal adenocarcinoma (PDA).
Decreased Bmal1 expression correlates with advanced TNM stage and poor histological differentiation of PDA.
Low Bmal1 expression is an independent prognostic factor for poor survival outcome for patients with PDA.